Table 1.
Demographic and clinical characteristics of the patients in the text-based symptom-monitoring program
| Breast N = 193 |
Ovarian N = 70 |
Endometrial N = 50 |
|
|---|---|---|---|
| Characteristics* | |||
| Age [mean (range)] | 55.2 (26–82) | 62.9 (35–87) | 63.1 (43–87) |
| Race [n (%)] | |||
| White | 163 (84.5%) | 58 (82.9%) | 44 (88.0%) |
| African American or Black | 21 (10.9%) | 8 (11.4%) | 5 (10.0%) |
| Other | 1 (0.5%) | 2 (2.9%) | 0 (0%) |
| Mixed/Unknown | 8 (4.1%) | 2 (2.9%) | 1 (2%) |
| Ethnicity [n (%)] | |||
| Not Hispanic/Latina | 192 (99.5%) | 68 (97.2) | 50 (100.0%) |
| Hispanic/Latina | 1 (0.5%) | 1 (1.4%) | 0 (0%) |
| Unknown | 0 (0%) | 1 (1.4%) | 0 (0%) |
| Marital status [n (%)] | |||
| Married/living as married | 136 (70.5%) | 33 (47.1%) | 22 (44.0%) |
| Divorced/Separated | 28 (14.5%) | 12 (17.1%) | 6 (12.0%) |
| Widowed | 11 (5.7%) | 6 (8.6%) | 2 (4.0%) |
| Single/Never married | 17 (8.8%) | 10 (14.3%) | 5 (10.0%) |
| Unknown | 1 (0.5%) | 9 (12.9%) | 15 (30.0%) |
| Education [n (%)] | |||
| ≤ High school graduate | 35 (18.1%) | 16 (22.9%) | 17 (34.0%) |
| Some college/technical school | 55 (28.5%) | 19 (27.1%) | 7 (14.0%) |
| College graduate | 62 (32.1%) | 14 (20.0%) | 6 (12.0%) |
| Post-graduate | 41 (21.2%) | 12 (17.1%) | 5 (10.0%) |
| Unknown | 0 | 9 (12.9%) | 15 (30.0%) |
| Income [n (%)] | |||
| < $35,000 | 44 (22.8%) | 15 (23.1%) | 11 (20.8%) |
| $35,000–$49,000 | 23 (11.9%) | 10 (16.1%) | 3 (8.6%) |
| $50,000–$74,999 | 26 (13.5%) | 5 (8.1%) | 6 (17.1%) |
| $75,000–$99,999 | 26 (13.5%) | 6 (9.7%) | 2 (5.7%) |
| > $100,000 | 44 (22.8%) | 12 (19.3%) | 3 (8.6%) |
| Unknown | 30 (15.5%) | 22 (31.4%) | 25 (50.0%) |
| Employment [n (%)] | |||
| Employed | 94 (48.7%) | 13 (18.6%) | 12 (24.0%) |
| Unemployed | 8 (4.1%) | 2 (2.9%) | 2 (4.0%) |
| Homemaker | 16 (8.3%) | 3 (4.3%) | 2 (4.0%) |
| Retired | 54 (28.0%) | 33 (47.1%) | 13 (26.0%) |
| Disabled | 17 (8.8%) | 6 (8.5%) | 5 (10.0%) |
| Other | 4 (2.1%) | 4 (5.7%) | 1 (1.0%) |
| Unknown | 0 (0%) | 9 (12.9%) | 15 (30.0%) |
| Metropolitan area | 145 (75.1%) | 50 (71.4%) | 27 (54.0%) |
| Non-Metropolitan area | 48 (24.8%) | 20 (28.6%) | 22 (46.0%) |
| Cancer stage [n (%)] | |||
| 0 | 6 (4.2%) | 1 (1.6%) | 4 (8.5%) |
| 1 | 41 (28.5%) | 18 (28.1%) | 12 (25.5%) |
| 2 | 45 (31.3%) | 16 (25%) | 15 (31.9%) |
| 3 | 25 (17.4%) | 21 (32.8%) | 12 (25.5%) |
| 4 | 27 (18.8%) | 8 (12.5%) | 4 (8.5%) |